Download PDF
Thromb Haemost 1975; 33(01): 017-019
DOI: 10.1055/s-0038-1647805
Meeting of the International Committee on Thrombosis and Haemostasis — Symposium on Heparin, Basel, Switzerland, September, 1974
Schattauer GmbH

The Physiological Function of Heparin[*]

F Koller
1   Department of Internal Medicine, Kantonsspital Basel, Switzerland
› Author Affiliations
Further Information

Publication History

Publication Date:
02 July 2018 (online)

Also available at
    Permissions and Reprints

 

* Introduction to the Symposium on Heparin, Basel, Switzerland, September, 1974.


 

  • References

  • 1 Ecker E. E, Pillemer C. Anticoagulants and complementary activity. An experimental study. Journal of Immunology 1941; 40: 73
    PubMedGoogle Scholar
  • 2 Heni F, Krauss I. Angeborene familiäre Gerinnungsstörung durch heparinartigen Hemmkörper. Klinische Wochenschrift 1956; 34: 747
    CrossrefPubMedGoogle Scholar
  • 3 Holmgren H. J, Wilander O. Beitrag zur Kenntnis der Chemie und Funktion der Ehrlich’schen Mastzellen. Zeitschrift für mikroskopisch-anatomische Forschung 1937; 42: 242.
    PubMedGoogle Scholar
  • 4 Jaques L. B, Waters E. T. The isolation of crystalline heparin from the blood of dogs in anaphylactic shock. American Journal of Physiology 1940; 129: 389
    PubMedGoogle Scholar
  • 5 Jorpes J. E. The chemistry of heparin. Biochemical Journal 1935; 29: 1817
    CrossrefPubMedGoogle Scholar
  • 6 Jorpes J. E. Heparin, its chemistry, physiology and application in medicine. Oxford University Press. 1939
    PubMedGoogle Scholar
  • 7 Jorpes J. E. Heparin in the treatment of thrombosis. 2nd ed.. Oxford University Press.; 1946
    Google Scholar
  • 8 Jorpes J. E. Heparin. In Handbuch für Experimentelle Pharmakologie Bd. XXVII: Antikoagulantien. Springer-Verlag; Berlin-Heidelberg-New York.: 1971
    Google Scholar
  • 9 Keller R. Personal communication.
    PubMedGoogle Scholar
  • 10 Lauenstein K, Siedentopf H. G, Fischer H. Üeber die Wirkung von Heparin, Heparinoiden und Carragenine auf die Komponenten des Meerschweinchen-Komplements in vitro. Zeitschrift für Naturforschung 1965; 206: 575.
    PubMedGoogle Scholar
  • 11 Ménache D. Abnormal fibrinogens. A review. Thrombosis et Diathesis Haemorrhagica 1973; 29: 525.
    PubMedGoogle Scholar
  • 12 Morrione Th.G. The formation of collagen fibers by the action of heparin on soluble collagen: An electron microscope study. Journal of Experimental Medicine 1952; 26: 107.
    PubMedGoogle Scholar
  • 13 Nilsson I. M, Blombäck M, Jorpes J. E, Blombäck B, Johannson S. A. Von Willebrand’s disease and its correction with human plasma fraction 1—0. Acta Medica Scandinavica 1957; 159: 179.
    PubMedGoogle Scholar
  • 14 Owren P. Acquired hemolytic jaundice. Scandinavian Journal of Clinical and Laboratory Investigations 1949; 1: 41.
    CrossrefPubMedGoogle Scholar
  • 15 Quick A. J, Hussey C. V. Hyperheparinemia. Report of a case. American Journal of Medical Science 1957; 234: 251.
    PubMedGoogle Scholar
  • 16 Quick A. J. Bleeding Problems in Clinical Medicine. W. B. Saunders Co.: Philadelphia.; 1970
    PubMedGoogle Scholar
  • 17 Rohr K. Das menschliche Knochenmark 3. Aufl., S. 86/87. 1960 Georg Thieme Verlag. Stuttgart.:
    PubMedGoogle Scholar
  • 18 Schmidt-Mühlheim A. Beiträge zur Kenntnis des Peptons und seiner physiologischen Bedeutung. Du Bois-Reymond Archiv für Physiologie 1880; 4: 33
    PubMedGoogle Scholar
  • 19 Schwarz E, Wanner J, Koller F. Über ein antithrombotisch wirkendes Anticoagulans bei Leberkrankheiten. Acta Haematologica, Basel 1951; 6: 70.
    PubMedGoogle Scholar
  • 20 Wilander O. Studien über das Heparin. Scandinavian Archives of Physiology 1938; 81 Suppl. 15.
    PubMedGoogle Scholar